Ticker

MOLN

Molecular Partners AG

11 catalysts on file

MOLN

Molecular Partners AG

Phase 1 AI-extracted

MP0317

advanced cancer types

963d ago Jan 1, 2024

SEC 6-K verified 2mo ago

Countdown card →

MOLN

Molecular Partners AG

Phase 1 AI-extracted

MP0712

small cell lung cancer

232d ago ~ Jan 1, 2026

SEC 6-K verified 2mo ago

Countdown card →

MOLN

Molecular Partners AG

PDUFA AI-extracted

MP0712

small cell lung cancer

147d ago Mar 27, 2026

SEC 6-K verified 2mo ago

Countdown card →

MOLN

Molecular Partners AG

Phase 2 AI-extracted

MP0317

advanced cancer types

52d ago ~ Jun 30, 2026

SEC 6-K verified 2mo ago

Countdown card →

MOLN

Molecular Partners AG

Phase 2 AI-extracted

MP0712

small cell lung cancer

52d ago Jun 30, 2026

SEC 6-K verified 2mo ago

Countdown card →

MOLN

Molecular Partners AG

Phase 1 AI-extracted

MP0726

ovarian cancer

52d ago ~ Jun 30, 2026

SEC 6-K verified 2mo ago

Countdown card →

MOLN

Molecular Partners AG

Phase 2 AI-extracted

MP0533

relapsed/refractory acute myeloid leukemia

52d ago ~ Jun 30, 2026

SEC 6-K verified 2mo ago

Countdown card →

MOLN

Molecular Partners AG

Phase 3 AI-extracted

MP0712

small cell lung cancer

T-minus 497 days ~ Dec 31, 2027

SEC 6-K verified 2mo ago

Countdown card →

MOLN

Molecular Partners AG

Phase 1 AI-extracted

MP0533

acute myeloid leukemia

Date TBD Date TBD

SEC 6-K verified 2mo ago

Countdown card →

MOLN

Molecular Partners AG

AdCom AI-extracted

MP0533

acute myeloid leukemia

Date TBD Date TBD

SEC 6-K verified 2mo ago

Countdown card →

MOLN

Molecular Partners AG

Phase 2 AI-extracted

MP0632

solid cancers expressing MSLN and EpCAM

Date TBD Date TBD

SEC 6-K verified 2mo ago

Countdown card →